➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Harvard Business School
Johnson and Johnson
Boehringer Ingelheim

Last Updated: October 18, 2021

DrugPatentWatch Database Preview

Patent: 7,537,795

➤ Get the DrugPatentWatch Daily Briefing

« Back to Dashboard

Summary for Patent: 7,537,795
Title:Transdermal drug delivery devices having coated microprotrusions
Abstract: A device (12) and method are provided for percutaneous transdermal delivery of a potent pharmacologically active agent. The agent is dissolved in water to form an aqueous coating solution having an appropriate viscosity for coating extremely tiny skin piercing elements (10). The coating solution is applied to the skin piercing elements (10) using known coating techniques and then dried. The device (12) is applied to the skin of a living animal (e.g., a human), causing the microprotrusions (10) to pierce the stratum corneum and deliver a therapeutically effect dose of the agent to the animal.
Inventor(s): Cormier; Michel J. N. (Mountain View, CA), Young; Wendy A. (San Jose, CA), Nyam; Kofi (Palo Alto, CA), Daddona; Peter E. (Menlo Park, CA)
Assignee: Alza Corporation (Mountain View, CA)
Application Number:10/045,842
Patent Claims:see list of patent claims

Details for Patent 7,537,795

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Nps Pharms Inc NATPARA parathyroid hormone INJECTABLE;INJECTION 125511 2015-01-23 ⤷  Free Forever Trial Alza Corporation (Mountain View, CA) 2020-10-26 RX Orphan search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

International Patent Family for US Patent 7,537,795

Country Patent Number Estimated Expiration
South Africa 200303988 ⤷  Free Forever Trial
World Intellectual Property Organization (WIPO) 02094368 ⤷  Free Forever Trial
United States of America 2002128599 ⤷  Free Forever Trial
United States of America 2006200069 ⤷  Free Forever Trial
United States of America 8663155 ⤷  Free Forever Trial
>Country >Patent Number >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.